USPTO serial 85233012
PREXIVA
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- YOUNG, CARRIE SKYE
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with PREXIVA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
New York, NY
New York, NY
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Katrina Edge
KATRINA EDGE PFIZER INC.150 E 42ND ST BSMT 2NEW YORK, NY 10017-5642UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Veterinary preparations for the prevention or treatment of ocular disorders; oral diseases; central nervous system diseases and disorders, namely central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, encephalitis, epilepsy, Alzheimer's, cerebral palsy, insomnia, seizure disorders; circulatory system diseases and disorders, namely disorders in blood circulation, hypertension, portal hypertension, pulmonary diseases, pulmonary hypertension and heart failure; immunological diseases and disorders, namely autoimmune diseases, immunologic deficiency syndromes; the cardio-vascular system; the respiratory system; musculoskeletal diseases and disorders, namely connective tissue diseases, bone diseases, osteoporosis, spinal diseases, back pain, fractures, sprains, cartilage injuries; the digestive system; genitourinary diseases, namely urological diseases, infertility, sexually transmitted diseases, inflammatory pelvic diseases; and reproductive health diseases and disorders, namely, male and female infertility, ovulation disorders, hormone replacement therapy indicated for the relief of menopause symptoms and the prevention of osteoporosis; veterinary preparations for the treatment or prevention of infectious diseases, obesity, behavioral disorders and inflammatory disorders; veterinary preparations for use in dermatology, oncology, hematology, ophthalmology, and gastroenterology; veterinary preparations, namely, dental preparations, namely a pharmaceutical drug or vaccine for the treatment or prevention of tooth decay, tooth sensitivity, gingivitis, halitosis and periodontal disease; veterinary preparations, namely, nutritional additives to foodstuffs for animals for medical purposes and food supplements; veterinary preparations, namely, pharmaceutical preparations for relieving teething pains and toothaches in companion animals; veterinary parasiticides; veterinary analgesic preparations; veterinary anti-allergen preparations, namely, allergy medications; veterinary preparations, namely, anti-infectives, anti-bacterials, anti-virals, antibiotics, antifungals | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 30, 2012 | MAB6 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jul 30, 2012 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Dec 27, 2011 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Nov 15, 2011 | ETOP | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED | — |
| Jun 2, 2011 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| May 3, 2011 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| May 3, 2011 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 23, 2011 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 22, 2011 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 8, 2011 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 7, 2011 | NWAP | NEW APPLICATION ENTERED | — |